Examining orthorexia nervosa in postmenopausal women with osteoporosis
Fragile Bones, Strong Obsessions: A Controlled Study on Orthorexia Nervosa, Body Image and Mood in Postmenopausal Women With Osteoporosis
This study is testing how healthy eating habits, known as orthorexia nervosa, might relate to bone health in postmenopausal women with osteoporosis compared to those without the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 128 (estimated) |
| Ages | 55 Years to 75 Years |
| Sex | Female |
| Sponsor | Beylikduzu State Hospital Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06947213 on ClinicalTrials.gov |
What this trial studies
This observational study will include 64 postmenopausal women diagnosed with osteoporosis and 64 age-matched healthy controls to investigate the relationship between orthorexia nervosa and osteoporosis. Participants will undergo assessments that include sociodemographic data collection, evaluation of bone mineral density through DXA scans, and psychological assessments using the ORTO-11 scale, Hospital Anxiety and Depression Scale, and Body Appreciation Scale-2. The study aims to gather comprehensive data on the psychological and physical health of women with osteoporosis compared to healthy controls.
Who should consider this trial
Good fit: Ideal candidates are postmenopausal women aged 55-75 diagnosed with osteoporosis or healthy women of similar age without osteoporosis.
Not a fit: Patients with psychiatric disorders, cognitive impairments, malignancies, or endocrine disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the psychological factors affecting women with osteoporosis, potentially leading to improved treatment strategies.
How similar studies have performed: While studies on osteoporosis are common, the specific focus on orthorexia nervosa in this context is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women between 55-75 years * Women diagnosed with osteoporosis based on DXA measurements performed within the past six months. * Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls). * Willingness to participate and provision of written informed consent. Exclusion Criteria: * Refusal to participate in the study. * Diagnosed psychiatric disorders. * Cognitive impairment. * Presence of malignancy. * Presence of endocrine disorders (e.g., hyperthyroidism, Cushing's syndrome). * Use of glucocorticoids. * Use of medications affecting mood.
Where this trial is running
Istanbul
- Beylikdüzü State Hospital — Istanbul, Turkey (Türkiye) (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.